Holdings
Rock Springs Capital Management LP
As of Sep 30, 2026, Rock Springs Capital Management LP reported 102 positions worth US$1.78B. Largest: Revolution Medicines, Inc., Travere Therapeutics, Inc. and Eli Lilly and Company. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Revolution Medicines, Inc. | 869K | US$178M | −236K | Sep 30, 2026 |
| Travere Therapeutics, Inc. | 2.2M | US$130M | +25,016 | Sep 30, 2026 |
| Eli Lilly and Company | 98,700 | US$114M | no change | Sep 30, 2026 |
| Madrigal Pharmaceuticals, Inc. | 177K | US$89.3M | +2,250 | Sep 30, 2026 |
| Mirum Pharmaceuticals, Inc. | 780K | US$66.7M | −18,355 | Sep 30, 2026 |
| Rhythm Pharmaceuticals, Inc. | 693K | US$65.9M | no change | Sep 30, 2026 |
| Kymera Therapeutics, Inc. | 410K | US$45.8M | −43,525 | Sep 30, 2026 |
| Insmed Incorporated | 365K | US$41.7M | +3,100 | Sep 30, 2026 |
| UnitedHealth Group Incorporated | 92,250 | US$33.9M | +28,500 | Sep 30, 2026 |
| Scholar Rock Holding Corporation | 683K | US$33M | −32,798 | Sep 30, 2026 |